Global Gastro Esophageal Reflux Disease (GERD) Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gastro Esophageal Reflux Disease (GERD) Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gastro Esophageal Reflux Disease (GERD) Drug by Country/Region, 2017, 2022 & 2028

2.2 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type

2.2.1 H2 Receptor Antagonist

2.2.2 Proton Pump Inhibitor (PPi)

2.2.3 Antacids

2.3 Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type

2.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Price by Type (2017-2022)

2.4 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Medical Center

2.4.4 Others

2.5 Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

2.5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Price by Application (2017-2022)

3 Global Gastro Esophageal Reflux Disease (GERD) Drug by Company

3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by Company

3.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Sales by Company (2020-2022)

3.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2020-2022)

3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Company (2020-2022)

3.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Company (2020-2022)

3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Price by Company

3.4 Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Location Distribution

3.4.2 Players Gastro Esophageal Reflux Disease (GERD) Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gastro Esophageal Reflux Disease (GERD) Drug by Geographic Region

4.1 World Historic Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Revenue by Geographic Region

4.2 World Historic Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Revenue by Country/Region

4.3 Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth

4.4 APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth

4.5 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth

4.6 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth

5 Americas

5.1 Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country

5.1.1 Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022)

5.1.2 Americas Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022)

5.2 Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type

5.3 Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region

6.1.1 APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022)

6.1.2 APAC Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022)

6.2 APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type

6.3 APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug by Country

7.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022)

7.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022)

7.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type

7.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug by Country

8.1.1 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type

8.3 Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gastro Esophageal Reflux Disease (GERD) Drug

10.3 Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug

10.4 Industry Chain Structure of Gastro Esophageal Reflux Disease (GERD) Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors

11.3 Gastro Esophageal Reflux Disease (GERD) Drug Customer

12 World Forecast Review for Gastro Esophageal Reflux Disease (GERD) Drug by Geographic Region

12.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Region

12.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecast by Region (2023-2028)

12.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecast by Type

12.7 Global Gastro Esophageal Reflux Disease (GERD) Drug Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Novartis AG

13.2.1 Novartis AG Company Information

13.2.2 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis AG Main Business Overview

13.2.5 Novartis AG Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Medtronic

13.5.1 Medtronic Company Information

13.5.2 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Medtronic Main Business Overview

13.5.5 Medtronic Latest Developments

13.6 The Kroger Co.

13.6.1 The Kroger Co. Company Information

13.6.2 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 The Kroger Co. Main Business Overview

13.6.5 The Kroger Co. Latest Developments

13.7 Aros Pharma

13.7.1 Aros Pharma Company Information

13.7.2 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.7.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aros Pharma Main Business Overview

13.7.5 Aros Pharma Latest Developments

13.8 AstraZeneca, Plc.

13.8.1 AstraZeneca, Plc. Company Information

13.8.2 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AstraZeneca, Plc. Main Business Overview

13.8.5 AstraZeneca, Plc. Latest Developments

13.9 Addex Therapeutics

13.9.1 Addex Therapeutics Company Information

13.9.2 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Addex Therapeutics Main Business Overview

13.9.5 Addex Therapeutics Latest Developments

13.10 Takeda Pharmaceutical Company Limited

13.10.1 Takeda Pharmaceutical Company Limited Company Information

13.10.2 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

13.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.10.5 Takeda Pharmaceutical Company Limited Latest Developments

14 Research Findings and Conclusion

Table 1. Gastro Esophageal Reflux Disease (GERD) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gastro Esophageal Reflux Disease (GERD) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of H2 Receptor Antagonist

Table 4. Major Players of Proton Pump Inhibitor (PPi)

Table 5. Major Players of Antacids

Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)

Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)

Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022)

Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Company (2020-2022)

Table 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Producing Area Distribution and Sales Area

Table 22. Players Gastro Esophageal Reflux Disease (GERD) Drug Products Offered

Table 23. Gastro Esophageal Reflux Disease (GERD) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Gastro Esophageal Reflux Disease (GERD) Drug

Table 67. Key Market Challenges & Risks of Gastro Esophageal Reflux Disease (GERD) Drug

Table 68. Key Industry Trends of Gastro Esophageal Reflux Disease (GERD) Drug

Table 69. Gastro Esophageal Reflux Disease (GERD) Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List

Table 72. Gastro Esophageal Reflux Disease (GERD) Drug Customer List

Table 73. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Forecast by Region

Table 75. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 95. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Novartis AG Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 100. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Novartis AG Main Business

Table 102. Novartis AG Latest Developments

Table 103. GlaxoSmithKline Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 105. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. GlaxoSmithKline Main Business

Table 107. GlaxoSmithKline Latest Developments

Table 108. Merck Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 110. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Merck Main Business

Table 112. Merck Latest Developments

Table 113. Medtronic Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 115. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Medtronic Main Business

Table 117. Medtronic Latest Developments

Table 118. The Kroger Co. Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 120. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. The Kroger Co. Main Business

Table 122. The Kroger Co. Latest Developments

Table 123. Aros Pharma Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 125. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Aros Pharma Main Business

Table 127. Aros Pharma Latest Developments

Table 128. AstraZeneca, Plc. Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 130. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. AstraZeneca, Plc. Main Business

Table 132. AstraZeneca, Plc. Latest Developments

Table 133. Addex Therapeutics Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 135. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. Addex Therapeutics Main Business

Table 137. Addex Therapeutics Latest Developments

Table 138. Takeda Pharmaceutical Company Limited Basic Information, Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Offered

Table 140. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. Takeda Pharmaceutical Company Limited Main Business

Table 142. Takeda Pharmaceutical Company Limited Latest Developments

List of Figures

Figure 1. Picture of Gastro Esophageal Reflux Disease (GERD) Drug

Figure 2. Gastro Esophageal Reflux Disease (GERD) Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of H2 Receptor Antagonist

Figure 10. Product Picture of Proton Pump Inhibitor (PPi)

Figure 11. Product Picture of Antacids

Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type in 2021

Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2022)

Figure 14. Gastro Esophageal Reflux Disease (GERD) Drug Consumed in Hospital

Figure 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 16. Gastro Esophageal Reflux Disease (GERD) Drug Consumed in Clinic

Figure 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Gastro Esophageal Reflux Disease (GERD) Drug Consumed in Medical Center

Figure 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Medical Center (2017-2022) & (K Pcs)

Figure 20. Gastro Esophageal Reflux Disease (GERD) Drug Consumed in Others

Figure 21. Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application in 2021

Figure 24. Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Company in 2021

Figure 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales 2017-2022 (K Pcs)

Figure 31. Americas Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales 2017-2022 (K Pcs)

Figure 33. APAC Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales 2017-2022 (K Pcs)

Figure 35. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country in 2021

Figure 39. Americas Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country in 2021

Figure 40. United States Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region in 2021

Figure 45. APAC Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Regions in 2021

Figure 46. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country in 2021

Figure 53. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country in 2021

Figure 54. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Gastro Esophageal Reflux Disease (GERD) Drug in 2021

Figure 67. Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug

Figure 68. Industry Chain Structure of Gastro Esophageal Reflux Disease (GERD) Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles